NCT01538589已完成不适用
Special Survey for Type 1 or Type 2 Diabetic Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,582
- 主要终点
- Adverse events
研究概览
简要总结
This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia under normal clinical practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with no treatment history of insulin aspart (NovoRapid®)
排除标准
- 未提供
研究组 & 干预措施
Insulin aspart users
干预措施: insulin aspart (Drug)
结局指标
主要结局
Adverse events
时间窗: Year 2 for patients who had an antibody titre test performed
Occurrence of severe hypoglycaemic symptoms
时间窗: Year 2 for patients who had an antibody titre test performed
Antibody titre findings
时间窗: Year 2 for patients who had an antibody titre test performed
次要结局
- Total dose of insulin infused subcutaneously(Year 2 for patients who had an antibody titre test performed)
- Response rate assessed by the investigator: Ability or failure to achieve expected glycaemic control(Year 2 for patients who had an antibody titre test performed)
- HbA1c (glycosylated haemoglobin)(Year 2 for patients who had an antibody titre test performed)
研究者
相似试验
已完成
不适用
Special Survey for Type 1 or Type 2 Diabetic PatientsDiabetesDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1NCT01487408Novo Nordisk A/S1,463
已完成
2 期
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)Diabetic NephropathiesNCT01968668Bayer96
已完成
不适用
Hypoglycaemia in People With Type 2 Diabetes in Primary CareDiabetes Mellitus, Type 2HypoglycemiaNCT02666521University of Leicester2,327
Unknown
不适用
Korea National Diabetes ProgramDiagnosisTreatmentPreventionComplicationsType 2 Diabetes MellitusNCT01212198Kyunghee University Medical Center6,000
已完成
不适用
A Survey on Low Blod Sugar Among Insulin-treated Patients With DiabetesDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2NCT02306681Novo Nordisk A/S7,315